Research.Patient.info
Anaplastic Large T-cell Lymphoma ALK negative research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingPhase I and Phase II (Integrated)- Other
ROMIDEPSIN IN COMBINATION WITH CHOEP AS FIRST LINE TREATMENT BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION IN YOUNG PATIENTS WITH NODAL PERIPHERAL T-CELL LYMPHOMAS: A PHASE I-II STUDY
This study looks at a new drug, Romidepsin, combined with standard treatment (CHOEP) for young people with certain types of lymphoma. It aims to find the safest dose and see how well it works before a stem cell transplant.
Italy - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A safety study of PF-08046045/SGN-35T in adults with advanced cancers
Germany · Spain · Denmark